Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypersensitivity Reaction
  Free Subscription

Articles published in
J Dermatol
    September 2025
  1. DEKIO I, Katsuta M, Ishiuji Y, Nobeyama Y, et al
    Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023).
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17927.
    >> Share

    August 2025
  2. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17915.
    >> Share

  3. MATSUO M, Takagi H, Iwata H
    A Case of Atopic Dermatitis Accompanied by Prurigo Nodularis Developed Eosinophilic Pneumonia on Dupilumab Therapy.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17892.
    >> Share

    July 2025
  4. SASAKI W, Saito R, Suzuki K, Watanabe D, et al
    Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Jul 23. doi: 10.1111/1346-8138.17877.
    >> Share

  5. TAKAMURA S, Sugai S, Fukuda T
    Long-Term Clinical Courses and Stratified Management of Dupilumab-Associated Inflammatory Arthritis in Atopic Dermatitis: Two Japanese Cases With Over 200 Weeks of Follow-Up and Musculoskeletal Ultrasound Assessment.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17873.
    >> Share

  6. CHEN HC, Chen YC, Chuang MH, Chien WC, et al
    Increased Risk of Chronic Kidney Disease in Atopic Dermatitis: A Nationwide, Population-Based Cohort Analysis.
    J Dermatol. 2025 Jul 10. doi: 10.1111/1346-8138.17841.
    >> Share

    June 2025
  7. YUNOKI M, Kondo S, Otsuka M, Tokura Y, et al
    A Case of Anaphylaxis to Persulfate Salts Contained in Hair Bleaching Powder, Showing Exclusive Immediate-Type but not Delayed-Type Allergy.
    J Dermatol. 2025 Jun 27. doi: 10.1111/1346-8138.17837.
    >> Share

  8. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment for Atopic Dermatitis-Induced Rash on the Face and Neck: Efficacy at Reducing Local Side Effects of Topical Steroid and Tacrolimus Ointment.
    J Dermatol. 2025 Jun 26. doi: 10.1111/1346-8138.17817.
    >> Share

  9. KAWAKAMI D, Hagihara E, Hata T, Hasegawa J, et al
    Coconut Anaphylaxis Induced by Occupational Sensitization to Cosmetics via the Skin in a Spa Therapist.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17820.
    >> Share

  10. TONE Y, Matsui M, Park A, Otani S, et al
    A Case of Stevens-Johnson Syndrome Induced by Selpercatinib.
    J Dermatol. 2025;52:1066-1069.
    >> Share

  11. SUEKI H, Sugiyama S, Aoyama Y, Yamamoto T, et al
    Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
    J Dermatol. 2025;52:1015-1030.
    >> Share

    May 2025
  12. AKAI N, Hashimoto T, Okuno S, Takai S, et al
    Apalutamide-Induced Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms Involving Reactivation of Human Herpesvirus-6 and Cytomegalovirus: A Case Report.
    J Dermatol. 2025 May 19. doi: 10.1111/1346-8138.17787.
    >> Share

  13. LI C, Dai M, Gu Q, Lu K, et al
    Incidence of the Stevens-Johnson syndrome spectrum and its patterns in urban China.
    J Dermatol. 2025;52:897-906.
    >> Share

  14. TANEMURA A, Ma Y, Sakaki-Yumoto M, Hiro S, et al
    Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
    J Dermatol. 2025;52:831-840.
    >> Share

    April 2025
  15. SHEN MH, An HY, Shih CL
    Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis.
    J Dermatol. 2025 Apr 12. doi: 10.1111/1346-8138.17738.
    >> Share

  16. YAMAMURA S, Myangat TM, Sawamura S, Shimada S, et al
    Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis.
    J Dermatol. 2025 Apr 1. doi: 10.1111/1346-8138.17727.
    >> Share

    March 2025
  17. CHO YT, Chou HI, Chan TC, Chen YC, et al
    Disease burden and treatment preference for moderate-to-severe atopic dermatitis in Taiwan: A discrete-choice experiment.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17721.
    >> Share

  18. MORI Y, Okamoto-Kawai N, Inuo C, Matsumoto S, et al
    Usefulness of gibberellin-regulated protein specific IgE measurement in patients with systemic symptoms of apple allergy with exercise.
    J Dermatol. 2025 Mar 12. doi: 10.1111/1346-8138.17691.
    >> Share

  19. TAKEUCHI S, Zeze N, Imayama S, Nakahara T, et al
    Case of allergic contact dermatitis caused by polyurethane elastic cannula.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17687.
    >> Share

  20. KUBO A
    History and prospects of Nagashima-type palmoplantar keratosis, the most common palmoplantar keratoderma in east Asian populations.
    J Dermatol. 2025;52:408-415.
    >> Share

  21. KIM MH
    Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID-19 infection: A nationwide population-based study.
    J Dermatol. 2025;52:499-504.
    >> Share

    February 2025
  22. HAMASAKI M, Sakai T, Hatano Y
    Cochineal allergy confirmed by specific IgE testing: Review of diagnostic sensitivity.
    J Dermatol. 2025 Feb 20. doi: 10.1111/1346-8138.17674.
    >> Share

  23. KAWAMOTO M, Sakai T, Uchimura K, Shono T, et al
    Anaphylaxis triggered by dog contact and exhaustion in a dog-allergic patient with atopic dermatitis.
    J Dermatol. 2025 Feb 17. doi: 10.1111/1346-8138.17676.
    >> Share

  24. VAN BUCHEM-POST NF, Ouwerkerk W, Stalman EW, van Dam KPJ, et al
    Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
    J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17664.
    >> Share

  25. MA Y, Chachin M, Hirose T, Nakamura K, et al
    Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17643.
    >> Share

  26. MIZUKAWA Y, Hama N, Niihara H, Miyagawa F, et al
    Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
    J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17609.
    >> Share

  27. YAMAMOTO T
    Erythroderma in the elderly.
    J Dermatol. 2025;52:221-227.
    >> Share

  28. MORIOKE S, Moriwaki M, Tanaka A, Hide M, et al
    A case of chronic spontaneous urticaria with wheals lasting for more than a week.
    J Dermatol. 2025;52:344-347.
    >> Share

  29. HIDE M, Kishimoto M, Kotera I, Oh A, et al
    Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes.
    J Dermatol. 2025;52:256-269.
    >> Share

    January 2025
  30. SUGIYAMA A, Yano-Takamori A, Kojima K, Nishie H, et al
    Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events.
    J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17626.
    >> Share

  31. TRUPIANO N, Young K, Echuri H, Maghfour J, et al
    Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
    J Dermatol. 2025 Jan 15. doi: 10.1111/1346-8138.17622.
    >> Share

  32. CHIBA K, Shibata Y, Nobeyama Y, Ohko K, et al
    A case of allergic urticaria induced by green tea and matcha.
    J Dermatol. 2025 Jan 8. doi: 10.1111/1346-8138.17624.
    >> Share

    December 2024
  33. SAEKI H, Ohya Y, Arakawa H, Ichiyama S, et al
    English version of clinical practice guidelines for the management of atopic dermatitis 2024.
    J Dermatol. 2024 Dec 20. doi: 10.1111/1346-8138.17544.
    >> Share

  34. KAMADA H, Arakawa N, Kato M, Tanji T, et al
    Nemolizumab-induced exacerbation of atopic dermatitis.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17589.
    >> Share

  35. IGARASHI A, Tsuji G, Murata R, Fukasawa S, et al
    A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17587.
    >> Share

    September 2024
  36. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
    >> Share

  37. SATO T, Nakazono M, Ohyachi K, Okaniwa A, et al
    HPV 51-associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17454.
    >> Share

  38. KUZUMI A, Yoshizaki A, Matsuda K, Nagai K, et al
    Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.
    J Dermatol. 2024;51:1240-1244.
    >> Share

  39. ENDO M, Yamamoto T
    Sarcoid reaction in lymph node metastasis of genital Paget disease.
    J Dermatol. 2024;51:e302-e303.
    >> Share

  40. KAMIGA M, Hayashi S, Ikegami T, Tokoro S, et al
    Hereditary angioedema with a normal C1 inhibitor in Japanese man.
    J Dermatol. 2024;51:e298-e299.
    >> Share

  41. MASUYUKI R, Sato E, Imafuku S
    A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.
    J Dermatol. 2024;51:1252-1255.
    >> Share

    August 2024
  42. MATSUMOTO C, Kawakami Y, Ishibashi O, Sagara I, et al
    A clinical case of anaphylaxis after eating oatmeal contaminated with booklice (Liposcelis bostrychophila).
    J Dermatol. 2024 Aug 10. doi: 10.1111/1346-8138.17419.
    >> Share

    July 2024
  43. MINAMI Y, Kanzaki M, Egusa C, Ito T, et al
    A case of anaphylaxis after ingestion of Enokitake (Flammulina velutipes): Detection of the causative antigens.
    J Dermatol. 2024 Jul 12. doi: 10.1111/1346-8138.17383.
    >> Share

    June 2024
  44. HIOKI C, Oda Y, Moriwaki S, Fukunaga A, et al
    Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases.
    J Dermatol. 2024;51:873-877.
    >> Share

    May 2024
  45. YOSHIDA K, Numata T, Sugisaki R, Ito T, et al
    Orofacial granulomatosis associated with indium allergy and apical periodontitis.
    J Dermatol. 2024 May 31. doi: 10.1111/1346-8138.17286.
    >> Share

  46. TAIRA H, Ito Y, Yamamoto T, Koyama A, et al
    Elevated serum vasohibin-1 levels in atopic dermatitis: Implications for disease chronicity.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17259.
    >> Share

    April 2024
  47. TANAKA A, Yuasa A, Kamei K, Nagano M, et al
    Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.
    J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17234.
    >> Share

  48. FUJIOKA K, Kita M, Iwata M, Moriue T, et al
    Multiple cutaneous focal mucinosis in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17213.
    >> Share

  49. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
    Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
    >> Share

  50. BABA A, Yamada K, Kanekura T
    Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17188.
    >> Share

  51. LIU Q, Su H, Hong C, Han J, et al
    Toxic epidermal necrolysis complicated with primary cutaneous aspergillosis: A report of four cases.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17226.
    >> Share

  52. HANAMI Y, Yamamoto T
    Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
    >> Share

  53. PAN X, Dong Z
    Yellow urticaria following plasma transfusion.
    J Dermatol. 2024;51:e108-e109.
    >> Share

  54. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
    Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    J Dermatol. 2024;51:509-517.
    >> Share

    March 2024
  55. HEMMI A, Okamura K, Nikaido M, Saito T, et al
    Post-COVID-19 vaccination diffuse cutaneous sarcoidosis.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17194.
    >> Share

  56. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
    Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
    >> Share

    February 2024
  57. HASHIZUME H, Ishikawa Y, Hata A
    Increased Demodex mites after dupilumab therapy in facial skin: A case report.
    J Dermatol. 2024 Feb 29. doi: 10.1111/1346-8138.17150.
    >> Share

  58. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
    Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
    >> Share

    December 2023
  59. NAKAIZUMI H, Kambe N, Irie H, Kaku Y, et al
    Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
    J Dermatol. 2023 Dec 6. doi: 10.1111/1346-8138.17067.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016